Loratadine and Soliris drug interactions - a phase IV clinical study of FDA data

Summary:

Drug interactions are reported among people who take Loratadine (loratadine) and Soliris (eculizumab). Common drug interactions include rash among females and haemolysis among males.

The phase IV clinical study analyzes what interactions people have when they take Loratadine and Soliris. It is created by eHealthMe based on reports of 60 people who take the same drugs from the FDA, and is updated regularly.

What is Loratadine?

Loratadine has active ingredients of loratadine. It is often used in allergies. eHealthMe is studying from 56,314 Loratadine users. Check the latest studies of Loratadine.

What is Soliris?

Soliris has active ingredients of eculizumab. It is often used in paroxysmal nocturnal hemoglobinuria (pnh). eHealthMe is studying from 58,821 Soliris users. Check the latest studies of Soliris.



On Jul, 15, 2026

60 people who take Loratadine and Soliris together, and have interactions are studied.

Loratadine and Soliris drug interactions.

What are the common drug interactions of Loratadine and Soliris, by gender? *:

female:

  1. Rash
  2. Urinary tract infection
  3. Urticaria (rash of round, red welts on the skin that itch intensely)
  4. Blood pressure increased
  5. Peripheral swelling
  6. Fatigue (feeling of tiredness)
  7. Pelvic pain
  8. Arthralgia (joint pain)
  9. Pyrexia (fever)
  10. Back pain

male:

  1. Haemolysis (breaking open of red blood cells and the release of haemoglobin into the surrounding fluid)
  2. Meningitis meningococcal (a bacterial infection of the membranes covering the brain and spinal cord (meninges))
  3. Cardiac tamponade (fluid accumulates in heart covering)
  4. Delusion (a false belief or opinion)
  5. Depression
  6. Enterococcal infection
  7. Escherichia infection (bacterial infection by escherichia coli)
  8. Fall
  9. Fatigue (feeling of tiredness)
  10. Fungal infection

What are the common drug interactions of Loratadine and Soliris, by age (0-1 to 60+)? *:

0-1:

n/a

2-9:

n/a

10-19:

  1. Fatigue (feeling of tiredness)
  2. Migraine (headache)
  3. Proteinuria (presence of protein in the urine)
  4. Asthma
  5. Blood creatinine increased
  6. Dyspnoea exertional (breathlessness or shortness of breath)

20-29:

  1. Abdominal pain
  2. Allergic cough
  3. Cough
  4. Drug hypersensitivity
  5. Dysphonia (speech disorder attributable to a disorder of phonation)
  6. Haemoglobinuria (the presence of free haemoglobin in the urine)
  7. Haemolysis (breaking open of red blood cells and the release of haemoglobin into the surrounding fluid)
  8. Hypersensitivity
  9. Pruritus generalised (generalized itching)
  10. Skin lesion

30-39:

  1. Thrombocytopenia (decrease of platelets in blood)
  2. Fatigue (feeling of tiredness)
  3. Nausea (feeling of having an urge to vomit)
  4. Rhinorrhoea (watery mucus discharge from the nose)
  5. Vomiting
  6. Back pain
  7. Haemoglobin decreased
  8. Bacteraemia (presence of bacteria in the blood)
  9. Chest pain
  10. Clostridial infection (infectious conditions by clostridium bacteria)

40-49:

  1. Ear discomfort
  2. Fluid retention (an abnormal accumulation of fluid in the blood)
  3. Muscle spasms (muscle contraction)
  4. Precancerous cells present
  5. Seizure (abnormal excessive or synchronous neuronal activity in the brain)

50-59:

  1. Blood pressure increased
  2. Peripheral swelling
  3. Fatigue (feeling of tiredness)
  4. Feeling jittery
  5. Headache (pain in head)
  6. Muscular weakness (muscle weakness)

60+:

  1. Arthralgia (joint pain)
  2. Fatigue (feeling of tiredness)
  3. Essential thrombocythaemia (chronic blood cancer)
  4. Infusion site extravasation (flow of (blood or lymph) from infusion site)
  5. Infusion site haematoma (localized swelling filled with blood at infusion site)
  6. Muscular weakness (muscle weakness)
  7. Myasthenia gravis (a chronic condition that causes muscles to tire and weaken easily)
  8. Cholecystitis (infection of gallbladder)
  9. Cholelithiasis (the presence or formation of gallstones in the gallbladder or bile ducts)
  10. Dyspnoea (difficult or laboured respiration)

What are the existing conditions these people have? *

  1. Paroxysmal Nocturnal Haemoglobinuria (haemoglobin in the urine): 18 people, 30.00%
  2. Hypersensitivity: 12 people, 20.00%
  3. High Blood Pressure: 11 people, 18.33%
  4. Gastroesophageal Reflux Disease (a condition in which stomach contents leak backward from the stomach into the oesophagus): 7 people, 11.67%
  5. Haemolytic Uraemic Syndrome (blood clotting disease caused by e. coli infection, birth control pills, pneumonia, medications, and more): 6 people, 10.00%
  6. Pain: 4 people, 6.67%
  7. Migraine (headache): 4 people, 6.67%
  8. Hypothyroidism (abnormally low activity of the thyroid gland, resulting in retardation of growth and mental development): 4 people, 6.67%
  9. Myasthenia Gravis (a chronic condition that causes muscles to tire and weaken easily): 3 people, 5.00%

* Approximation only. Some reports may have incomplete information.

Do you take Loratadine and Soliris?

- Personalize this study to your gender, age, symptoms and drugs
- Predict drug outcomes for up to one year with AI
- Get an AI agent to monitor your drugs continuously



Related studies:

Effectiveness of, side effects of, and alternative drugs to the 2 drugs:

Browse all drug interactions of Loratadine and Soliris:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Sub-studies by gender and age:

Female: 0-1 2-9 10-19 20-29 30-39 40-49 50-59 60+

Male: 0-1 2-9 10-19 20-29 30-39 40-49 50-59 60+

Browse all side effects of Loratadine:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all side effects of Soliris:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all interactions between Loratadine and drugs from A to Z:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all interactions between Soliris and drugs from A to Z:

a b c d e f g h i j k l m n o p q r s t u v w x y z

How the study uses the data?

The study uses data from the FDA. It is based on loratadine and eculizumab (the active ingredients of Loratadine and Soliris, respectively), and Loratadine and Soliris (the brand names). Other drugs that have the same active ingredients (e.g. generic drugs) are not considered. Dosage of drugs is not considered in the study.

How to use the study?

DO NOT STOP MEDICATIONS without first consulting your doctor. If there are any serious or long term adverse effects discovered in the study, discuss the study with your doctor to ensure that proper medication management will be in place if applicable.

Who is eHealthMe?

With medical big data and proven AI/ML algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 800+ peer-reviewed medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).

WARNING, DISCLAIMER, USE FOR PUBLICATION

WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.

DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.

If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.



Recent studies on eHealthMe: